XML 24 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
EQUITY, RESTATED (Details Narrative) (USD $)
3 Months Ended
May 31, 2013
Advisory And Clinical [Member]
 
Restricted stock issued $ 153,013
Stock vesting period 10 years
Director [Member]
 
Common stock issued 100,000
Fair value 375,000
Stock compensation expense 250,000
Gross sales 5,000,000
Consultant [Member]
 
Common stock issued 12,000
Fair value $ 34,200